#United States #Philadelphia #Type 1 Diabetes #Clinical Research #Breakthrough T1D

Inaugural Breakthrough T1D Clinical Research Congress Set to Transform T1D Care

The first-ever Breakthrough T1D Clinical Research Congress (CRC 2026) is just around the corner, scheduled to take place from October 9 to 11, 2026, in the vibrant city of Philadelphia, Pennsylvania. This landmark event, organized by Breakthrough T1D—formerly the JDRF organization—aims to engage a wide array of global stakeholders in the field of Type 1 Diabetes (T1D). The congress will facilitate collaboration among leading clinicians, researchers, healthcare professionals, and advocates in T1D, all under the shared mission of improving lives and creating pathways toward a future free of this autoimmune condition.

A Unique Learning Opportunity

CRC 2026 promises a packed agenda featuring over 80 scientific sessions that delve into a variety of critical topics associated with Type 1 Diabetes. Attendees can anticipate discussions on:

• - The role of Artificial Intelligence in diabetes management.
• - Innovative approaches like Advanced Immune Profiling and Digital Twin Technologies.
• - Pathways to potential cures and disease-modifying therapies.
• - Solutions to the shortage of endocrinologists and unmet needs in diabetes care.

This congress serves as a unique platform for the exchange of ideas and insights across different disciplines, united by the urgency to improve treatment options and outcomes for individuals living with T1D.

Expert Insights from Global Leaders

Prominent figures in the field, such as Dr. Thomas Danne, Chief Medical Officer International, and Dr. Sanjoy Dutta, Chief Scientific Officer at Breakthrough T1D, will lead discussions on the evolution of T1D research and care. They emphasize that the focus is shifting from merely managing blood sugar to understanding the disease’s underlying mechanics. Together with a team of over a dozen esteemed speakers from 16 different countries, this collective effort will set the stage for groundbreaking advancements in T1D science.

Dr. Danne notes, “We are learning how to better protect insulin-producing cells and make daily care more precise. Understanding which approaches work for whom is crucial as we develop treatments more rapidly.”

Bridging Science with Real-World Applications

The congress is anchored on the belief that scientific breakthroughs must translate into practical guidance for those living with T1D. “Scientific advances can only create real change when they influence actual patient care,” says Dr. Anastasia Albanese-O'Neill, Senior Vice President of Medical Affairs at Breakthrough T1D. This philosophy supports a hands-on approach, where lived experiences directly inform and enhance the research agenda.

An Event Not to Miss

Marking a significant milestone, CRC 2026 is designed to catalyze new collaborations within the T1D community—a community poised at a critical juncture in its journey toward effective treatments and possible cures.

With the congress just days away, healthcare professionals, researchers, and community advocates are encouraged to register and join the conversation that is shaping the future of Type 1 Diabetes.

Conclusion

For more information on the congress, including participation details, please visit bt1dcongress.org. To explore the ongoing efforts and initiatives of Breakthrough T1D, visit breakthrought1d.org. The culmination of groundbreaking research and life-changing initiatives awaits at CRC 2026, underscoring the collective commitment to improve the lives of those affected by Type 1 Diabetes.